ALTERITY THERAPEUTICS LIMITED

Market Cap $15.96M Add to my watchlist

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Latest Threads

	Tag	Subject

See All Discussions

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $15.96M

Open	High	Low	Value	Volume
0.3¢	0.3¢	0.3¢	$1.937K	645.7K

Buyers (Bids)

No.	Vol.	Price($)
77	96988980	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	655773	2

View Market Depth

No.	Vol.	Price($)
55	77606522	0.002
23	116310099	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	4867441	3
0.004	132321201	25
0.005	22242406	25
0.006	23031950	19
0.007	47726651	22

Last trade - 10.00am 15/11/2024 (20 minute delay)

ATH (ASX) Chart